Search This Blog

Tuesday, March 18, 2025

Anti-Tesla protests funded by big-time California Dem donor

 Anti-Tesla protests are being fueled by a Democratic mega-donor — whose ex-husband is one of Elon Musk’s closest pals.

Billionaire Steve Jurvetson, 58, was an early investor in Tesla, served on its board until December 2020 and continues to sit on Musk’s SpaceX board. However, his ex-wife, California psychiatrist Karla Jurvetson, 58, doled out more than $500,000 to Indivisible Action, a political action group linked to a nonprofit directing the protests against Musk, according to public records.

Indivisible, a Washington-based advocacy group, is sponsoring “Musk or Us” demonstrations across the country this week. The group offers a “toolkit” on its website featuring graphics and anti-Tesla protest signs as well as information about how to conduct town halls.

Karla Jurvetson, a psychiatrist and the ex-wife of Elon Musk investor Steve Jurvetson, has emerged as a Democratic mega-donor. She doled out more than $9.5 million to Democrats last year, and has backed groups that promote women in politics.MediaNews Group via Getty Images
Steve Jurvetson (left), who is on the SpaceX board of directors, bailed out his friend Elon Musk when he was out of cash in 2008.Steve Jurvetson/ Facebook

Its website states: “Support the massive organizing effort it’s going to take to defend our democracy and one another against Trump’s authoritarian agenda.”

The group stands against Musk and his leadership of the Department of Government Efficiency (DOGE), an initiative to streamline the federal bureaucracy.

“Republicans are enabling Musk to make decisions and push policies that directly hurt working families while enriching billionaires like himself,” the group said on its website.

“We cannot allow Republicans to abandon their responsibility to uphold our constitution and serve their constituents in order to curry favor with Musk.”

Some protesters have vandalized Tesla vehicles and facilities across the country, with fires set and showrooms spray-painted.

Karla Jurvetson is known in Northern California as something of a Democratic mega-donor. In addition to Indivisible, she gave more than $9.5 million to Democratic progressive candidates, including former New York Rep. Jamaal Bowman, who lost his re-election bid last year, and Minnesota’s Rep. Ilhan Omar. She also donated more than $100,000 to Kamala Harris’ Victory Fund in 2023.

The Stanford-educated psychiatrist and mother of two married Jurvetson in 1990, filing for divorce in 2016, according to court records. A year later, Steve quit his venture capital firm, Draper Fisher Jurvetson, after it began an investigation into his romantic relationships with multiple women at the company.

“An internal investigation conducted by Draper Fisher Jurvetson … found that Jurvetson had affairs with multiple women at the same time,” said a report in Recode, a tech news website. “The women, who work in the tech industry, met him at professional conferences.”

Firefighters in Seattle work to douse a burning Tesla vehicle, which was set on fire during a protest against Elon Musk last week.Jonathan Choe / SWNS
Many of the protests against Musk were organized by Indivisible, an advocacy group backed by billionaire philanthropist George Soros. Karla Jurvetson gave more than $500,000 to Indivisible Action, a PAC associated with Indivisible, last year.ZUMAPRESS.com

The women discovered Jurvetson’s alleged duplicity at a TED conference in Vancouver in March 2015, according to Recode.

In a Facebook post on November 14, 2017, Jurvetson denied the allegations.

“Wholly false allegations about sexual predation and workplace harassment,” he said. “Let me be perfectly clear: no such allegations are true.

“I think my personal life, and other people’s personal lives, should stay personal,” Jurvetson continued. “It should not be in the court of public opinion. This is the last I will say on this subject for the foreseeable future.” Jurvetson remarried at the end of 2018, the same year he founded his new firm, Future Ventures.

Although both Jurvetsons supported the Democratic Party, Karla Jurvetson emerged as one of the most prolific donors to Democratic women in politics during the 2020 election cycle.

Protesters in Washington, DC, denounce Elon Musk and Donald Trump in protests backed by a nonprofit backed by the ex-wife of one of Musk’s biggest financial supporters.ZUMAPRESS.com

She donated nearly $15 million to Sen. Elizabeth Warren (D-Mass.), and in 2018 she doled out $30 million to the Emily’s List PAC, which supports pro-abortion candidates.

Steve Jurvetson has his own left-leaning charity alongside his new wife, the Jurvetson Foundation.

Protesters hold an anti-Musk banner during a demonstration against Tesla and Elon Musk outside a UK Tesla dealership.Vuk Valcic/SOPA Images/Shutterstock

He also continues to support Musk.

“The best investment I ever made — buying a Tesla for everyone in my family and at Future Ventures,” Jurvetson posted on X last week.

“Too precious to trust to anything but the safest car … especially for my co-founder who finally abandoned her motorcycle!”

Jurvetson has held important roles with Musk, helping to bail the billionaire out in 2008 when he was running out of cash to support Tesla and SpaceX.

“He’s really an American hero, more than anyone I’ve ever met,” Steve Jurvetson told Business Insider in 2012. “I was a believer all along.”

Neither Karla nor Steve Jurvetson returned The Post’s calls for comment.

https://nypost.com/2025/03/18/us-news/ex-wife-of-tesla-spacex-investor-fueling-anti-elon-musk-protests/

Walgreens chair Pessina to almost double stake as part of Sycamore deal

 The executive chairman of Walgreens Boots Alliance (NASDAQ:WBA), Stefano Pessina, is expected to nearly double his company ownership to about 30% after the U.S. pharmacy chain completes its buyout arrangement with private equity firm Sycamore, The Financial Times reported Tuesday.

The billionaire investor is Walgreens’ (NASDAQ:WBA) biggest shareholder, with an equity stake of about 17% worth as much as $2.1B currently.

New York-based Sycamore agreed to take the company private early this month in a deal worth about $10B that is expected to close in Q4 2025. A 35-day period in which WBA management can consider rival offers is currently ongoing.

The company had previously disclosed that Pessina would invest cash into the transaction and continue to hold significant equity ownership in the business he helped form in 2014 by combining European retailer Alliance Boots with U.S.-based Walgreens. However, the company hadn’t detailed the size of his post-transaction stake. 

https://www.msn.com/en-us/money/companies/walgreens-chair-pessina-to-almost-double-stake-as-part-of-sycamore-deal-ft/ar-AA1B9uP4

ANI Completes $17.25 M Buyout of Royalty Obligation for ILUVIEN and YUTIQ

 ANI Pharmaceuticals has paid $17.25 million to buy out royalty obligations for ILUVIEN and YUTIQ, enhancing financial flexibility.

ANI Pharmaceuticals, Inc. has announced the completion of a $17.25 million buyout of a 3.125% perpetual royalty obligation to SWK Funding LLC for the net revenues of their products ILUVIEN and YUTIQ, effective January 1, 2025. This move aims to enhance the company's financial flexibility and support the growth of its Retina portfolio. ANI funded the buyout using cash on hand and emphasizes its commitment to "Serving Patients, Improving Lives." The company is focused on sustainable growth in areas such as ophthalmology, rheumatology, and more, while also navigating various risks associated with commercialization and production.

Potential Positives

  • ANI Pharmaceuticals has successfully eliminated a 3.125% perpetual royalty obligation, enhancing financial flexibility and potential profitability moving forward.
  • The one-time payment of $17.25 million was funded with cash on hand, indicating strong liquidity and financial management.
  • This transaction demonstrates the company's commitment to strengthening its Retina portfolio, positioning it for accelerated growth in the future.

Potential Negatives

  • ANI Pharmaceuticals incurred a one-time payment of $17.25 million to buy out its royalty obligation, which may indicate financial strain or a need to restructure its financial commitments.
  • The reliance on cash on hand to fund the buyout could signal liquidity concerns if the Company faces future unexpected costs or downturns.
  • The report hints at uncertainties regarding the commercialization and market acceptance of its approved products, including potential risks that could impact profitability.
  • https://www.nasdaq.com/articles/ani-pharmaceuticals-completes-1725-million-buyout-royalty-obligation-iluvien-and-yutiq

'Ukrainian Telecom Group Kyivstar to Go Public on Nasdaq at $2.21 Billion Valuation'

 Ukraine’s Kyivstar Group said it plans to list on the Nasdaq in the coming months at a $2.21 billion valuation, betting on the tech-heavy U.S. index to attract international investors.

Veon, the digital operator that controls Kyivstar, said it signed an agreement with special purpose acquisition company Cohen Circle Acquisition Corp. I to list the Ukrainian telecommunication group on the Nasdaq Stock Market under the ticker KYIV.

“Investing in Kyivstar now becomes more directly accessible to international investors as Kyivstar progresses towards becoming a Nasdaq-listed company,” Veon Chief Executive Kaan Terzioglu said in a statement.

Veon said it would own at least 80% of the issued and outstanding equity of Kyivstar Group immediately after the listing, expected in the third quarter subject to approval from Cohen Circle’s shareholders and other conditions.

The announcement comes two months after Veon said it had inked a letter of intent to enter into a business combination with Cohen Circle Acquisition Corp. I, a SPAC backed by investment firm Cohen Circle.

Betsy Cohen, chief executive of the SPAC, said Kyivstar represents a significant investment opportunity for international investors once Ukraine moves into a rebuilding phase. President Trump is set to speak to Russian President Vladimir Putin on Tuesday as part of efforts from the White House to bring the war to an end.

Founded in 1994, Kyivstar counted more than 23 million mobile subscribers and more than 1.1 million home internet fixed line customers as of December last year. The group’s consumer digital service portfolio includes healthcare platform Helsi, with more than 28 million registered patients, and streaming platform Kyivstar TV, with 2 million monthly active users.

Kyivstar in December signed an agreement with Elon Musk’s Starlink to bring direct-to-cell satellite connectivity to Ukraine. The company expects to launch Starlink direct-to-cell services with messaging functionalities in the fourth quarter, before subsequently expanding to voice and data services.

https://www.msn.com/en-us/money/companies/ukrainian-telecom-group-kyivstar-to-go-public-on-nasdaq-at-2-21-billion-valuation/ar-AA1B9hA7

Alvotech, Dr. Reddy’s: FDA accepts Biologic License Application for proposed biosimilar of Prolia

 Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted a 351(k) Biologic License Application (BLA) submission for AVT03, developed by Alvotech, a proposed biosimilar of Prolia® (denosumab) and Xgeva® (denosumab).


https://investors.alvotech.com/news-releases/news-release-details/alvotech-and-dr-reddys-announce-fda-acceptance-biologic-license